Table 1.
Clinicopathologic correlation of DCAF4L2 expression in human sporatic colorectal carcinoma
| DCAF4L2 | ||||
|---|---|---|---|---|
|
|
||||
| Feature | low | high* | χ2 | P value# |
| All cases | 43 | 44 | ||
| Gender | 0.3118 | 0.577 | ||
| Male | 26 | 24 | ||
| Female | 17 | 20 | ||
| Age | 0.0975 | 0.755 | ||
| >65 | 23 | 25 | ||
| ≤65 | 20 | 19 | ||
| Intravascular cancer embolus | 2.351 | 0.125 | ||
| Present | 6 | 12 | ||
| Absent | 37 | 32 | ||
| Perineuronal invasion | 3.433 | 0.064 | ||
| Present | 8 | 16 | ||
| Absent | 35 | 28 | ||
| Tumor size (cm) | 3.745 | 0.053 | ||
| >4 | 11 | 20 | ||
| ≤4 | 32 | 24 | ||
| T stage | 3.832 | 0.280 | ||
| T1 | 4 | 1 | ||
| T2 | 12 | 8 | ||
| T3 | 10 | 11 | ||
| T4 | 17 | 24 | ||
| N stage | 10.418 | 0.005 | ||
| N0 | 18 | 9 | ||
| N1 | 15 | 10 | ||
| N2 | 10 | 25 | ||
| M stage | 4.679 | 0.031 | ||
| M0 | 39 | 32 | ||
| M1 | 4 | 12 | ||
| Tumor stage | ||||
| I | 6 | 2 | 9.509 | 0.023 |
| II | 15 | 7 | ||
| III | 18 | 23 | ||
| IV | 4 | 12 | ||
*
The median expression level was used as the cutoff. Low expression of DCAF4L2 in 43 patients was classified as values below the 50th percentile. High DCAF4L2 expression in 44 patients was classified as values at or above the 50th percentile.
#
Pearson’s chi-square tests were used for analysis of correlation between DCAF4L2 and clinical features. Results were considered statistically significant at P<0.05.